Evolution of the Average Target: Dolby Laboratories, Inc.

Evolution of the Average Target - Dolby Laboratories, Inc.

Evolution of the Target Price: Dolby Laboratories, Inc.

Evolution of the Target Price - Dolby Laboratories, Inc.

Changes in Analyst Recommendations: Dolby Laboratories, Inc.

7f213327b079fe16faa0c90c.98fAUpgi3EW42hbkVh0oILS2YHu32WH0Q9-vxwvV6SE.nZK4G_tulwL57lKLAShuFIDgMyn9siemKpvOgkCjnE6dpqw9wXKqFvqbdQ~5df284eb4dc5c27b3b8b7f9e02c7e4be
19/11 Barrington Trims Price Target on Dolby Laboratories to $95 From $100, Keeps Outperform Rating MT
05/25/05 Baird Initiates Dolby Laboratories at Neutral With $74 Price Target MT
15/25/15 Dolby Laboratories' Immersive Media Innovation, Strategic Partnerships to Drive Long-Term Growth, Tigress Financial Partners Says MT
15/25/15 Tigress Adjusts Price Target on Dolby Laboratories to $114 From $112, Maintains Buy Rating MT
03/24/03 Barrington Upgrades Dolby Laboratories to Outperform From Market Perform, Price Target is $100 MT
04/23/04 Rosenblatt Adjusts Price Target on Dolby Laboratories to $98 From $93, Maintains Buy Rating MT
03/23/03 Rosenblatt Adjusts Price Target on Dolby Laboratories to $90 From $85, Maintains Buy Rating MT
18/22/18 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform as Economic Challenges Results in Lower Volumes MT
18/22/18 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform MT
07/22/07 Rosenblatt Adjusts Price Target on Dolby Laboratories to $85 From $90, Maintains Buy Rating MT
14/22/14 Tigress Financial Cuts Dolby Laboratories' Price Target to $116 From $128 'on Near-Term Valuation Rerating;' Buy Rating Kept MT
24/22/24 Rosenblatt Starts Dolby Laboratories at Buy With $90 Price Target MT
13/22/13 Barrington Research Lowers Price Target for Dolby Laboratories to $90 From $115, Maintains Outperform Rating MT
02/21/02 Dolby Laboratories : Barrington Upgrades Dolby Laboratories to Outperform From Market Perform "as New Initiatives Supplement Progress", Sets $115 Price Target MT
29/21/29 Dolby Laboratories : B. Riley Adjusts Dolby Laboratories' Price Target to $89 From $79, Keeps Neutral Rating MT
04/21/04 Dolby Laboratories : Barrington Research Downgrades Dolby Laboratories to Market Perform From Outperform MT
13/20/13 Dolby Laboratories : JP Morgan Adjusts Price Target for Dolby Laboratories to $90 From $78, Maintains Overweight Rating MT
13/20/13 Dolby Laboratories : B. Riley Adjusts Dolby Laboratories' Price Target to $79 from $73, Keeps Neutral Rating MT
13/20/13 Dolby Laboratories : Barrington Research Adjusts PT on Dolby Laboratories to $95 From $83, Citing 'Meaningful Positive Momentum;' Outperform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+36.04%
+8.95%
-1.78%
+73.21%
-1.71%
-8.68%
+8.19%
+5.99%
-14.26%
+0.56%
Average +10.65%
Weighted average by Cap. +10.32%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
58.07USD
Average target price
79.00USD
Spread / Average Target
+36.04%
High Price Target
90.00USD
Spread / Highest target
+54.99%
Low Price Target
62.00USD
Spread / Lowest Target
+6.77%

Analyst Consensus Detail

Analyst consensus - Dolby Laboratories, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Dolby Laboratories, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Dolby Laboratories, Inc.
  1. Stock Market
  2. Stocks
  3. DLB Stock
  4. Consensus Dolby Laboratories, Inc.